Testosterone Booster Market, by Component (Vitamins, D-Aspartic Acid, Zinc and Others), by Source (Mucuna Pruriens Ginseng, Oyster Extract, Fenugreek and Others), by Distribution Channel (Pharmacies, Hypermarkets & Supermarkets, Online Channels and Others), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Testosterone boosters are supplementary substances that can be used for the purpose of increasing testosterone levels in the blood. Testosterone boosters may provide the following benefits to people with low testosterone levels: increase sex drive, improve sexual function, increase muscle strength and physical endurance, and denser and stronger bones. The most common components for the supplements are vitamin B6, fenugreek, zinc, tribulus, magnesium, boron, diindolemethane, Eurycoma longifolia, and Maca extract.
Market Dynamics
Increasing initiatives by government and private organizations for testosterone deficiency are expected to drive the market growth during the forecast period. For instance, in December 2020, Association of British Clinical Diabetologists announced Launch of ABCD worldwide audit of testosterone deficiency in men with type 2 diabetes. In previous audits Association of British Clinical Diabetologist had found that the patients treated with medications in the real world tend to be different from those in clinical trials for example, heavier and more poorly controlled. Thus this ABCD audit is being set up to establish the extent to which the patients treated, and the impact on them of testosterone treatment, matches the findings in the clinical trials. Moreover, increasing prevalence of testosterone deficiency is expected to drive the market growth over the forecast period. For instance, according to an article published in South African Medical Journal in December 2019, prevalence of low testosterone among men with type 2 diabetes mellitus (T2DM) was high in South Africa in 2019. The prevalence of low serum total testosterone (LSTT) and low serum free testosterone (LSFT) was 35.8% and 16.2%, respectively and the prevalence of androgen deficiency symptoms using the Ageing Males’ Symptoms Scale (AMS) questionnaire was 74.5% and correlated poorly with LSTT or LSFT.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook